[
  {
    "generic_name": "Fentanyl",
    "brand_names": ["Duragesic", "Sublimaze", "Actiq"],
    "active_ingredients": "Fentanyl Citrate 50mcg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-9015",
    "nafdac_schedule": "schedule_2",
    "nafdac_schedule_date": "2005-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class A",
    "who_essential_medicine": true,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 3,
    "requires_photo_id": true,
    "therapeutic_class": "Opioid Analgesic",
    "pharmacological_class": "Synthetic Opioid",
    "mechanism_of_action": "Potent mu-opioid receptor agonist",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Respiratory rate, Pain level, Sedation, Addiction signs",
    "monitoring_frequency_days": 1,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Respiratory depression", "Acute asthma", "Paralytic ileus", "Known intolerance"],
    "allergy_cross_reactions": ["Other opioids", "Morphine", "Codeine"],
    "black_box_warning": true,
    "black_box_warning_text": "Fatal respiratory depression risk, extremely high addiction potential, 50-100x stronger than morphine, accidental exposure can be fatal",
    "major_drug_interactions": ["CNS depressants (fatal respiratory depression)", "MAOIs (severe reactions)", "Benzodiazepines (respiratory depression)", "Alcohol (fatal)"],
    "food_interactions": "Avoid alcohol completely",
    "search_keywords": ["fentanyl", "duragesic", "opioid", "severe pain", "cancer pain"],
    "generic_variations": ["Fentanyl Citrate", "Fentanyl Base"],
    "common_misspellings": ["Fentanl", "Fentanyll", "Phentanyl"],
    "safer_alternatives": ["Morphine (weaker)", "Oxycodone", "Methadone"],
    "cheaper_alternatives": ["Morphine", "Tramadol (much weaker)"],
    "notes": "Extremely potent opioid. 50-100x stronger than morphine. Reserved for severe cancer pain and anesthesia. High abuse and overdose risk.",
    "is_active": true
  },
  {
    "generic_name": "Methadone",
    "brand_names": ["Methadose", "Dolophine"],
    "active_ingredients": "Methadone HCl 10mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-9016",
    "nafdac_schedule": "schedule_2",
    "nafdac_schedule_date": "2005-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class A",
    "who_essential_medicine": true,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 7,
    "requires_photo_id": true,
    "therapeutic_class": "Opioid Analgesic/Addiction Treatment",
    "pharmacological_class": "Synthetic Opioid",
    "mechanism_of_action": "Long-acting mu-opioid receptor agonist",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "ECG (QT prolongation), Respiratory function, Addiction management",
    "monitoring_frequency_days": 7,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Respiratory depression", "Acute asthma", "QT prolongation", "Severe liver disease"],
    "allergy_cross_reactions": ["Other opioids"],
    "black_box_warning": true,
    "black_box_warning_text": "QT prolongation risk, respiratory depression, risk of addiction, requires specialized prescribing for opioid dependence treatment",
    "major_drug_interactions": ["CNS depressants (respiratory depression)", "QT-prolonging drugs (cardiac arrhythmia)", "CYP3A4 inhibitors (increased levels)", "Benzodiazepines (respiratory depression)"],
    "food_interactions": "Avoid alcohol, grapefruit juice",
    "search_keywords": ["methadone", "opioid addiction treatment", "maintenance therapy", "chronic pain"],
    "generic_variations": ["Methadone Hydrochloride"],
    "common_misspellings": ["Methadon", "Methedone"],
    "safer_alternatives": ["Buprenorphine (lower overdose risk)", "Naltrexone (for addiction)"],
    "cheaper_alternatives": ["Buprenorphine"],
    "notes": "Used for chronic pain and opioid addiction treatment. Long half-life (24-36 hours). QT prolongation risk requires ECG monitoring.",
    "is_active": true
  },
  {
    "generic_name": "Pethidine",
    "brand_names": ["Demerol", "Pethidine HCl"],
    "active_ingredients": "Pethidine HCl 50mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-9017",
    "nafdac_schedule": "schedule_2",
    "nafdac_schedule_date": "2005-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class A",
    "who_essential_medicine": true,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 3,
    "requires_photo_id": true,
    "therapeutic_class": "Opioid Analgesic",
    "pharmacological_class": "Synthetic Opioid",
    "mechanism_of_action": "Mu-opioid receptor agonist",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Pain level, Respiratory rate, Seizure risk (normeperidine accumulation)",
    "monitoring_frequency_days": 3,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Respiratory depression", "MAO inhibitor use (within 14 days)", "Severe renal impairment"],
    "allergy_cross_reactions": ["Other opioids"],
    "black_box_warning": true,
    "black_box_warning_text": "Neurotoxic metabolite (normeperidine) accumulation can cause seizures, not recommended for chronic use, addiction risk",
    "major_drug_interactions": ["MAOIs (serotonin syndrome, fatal)", "CNS depressants (respiratory depression)", "Phenytoin (reduced efficacy)"],
    "food_interactions": "Avoid alcohol",
    "search_keywords": ["pethidine", "meperidine", "demerol", "labor pain", "acute pain"],
    "generic_variations": ["Meperidine", "Pethidine Hydrochloride"],
    "common_misspellings": ["Pethadin", "Pethidene", "Meperidene"],
    "safer_alternatives": ["Morphine (no toxic metabolite)", "Fentanyl", "Oxycodone"],
    "cheaper_alternatives": ["Morphine", "Tramadol (weaker)"],
    "notes": "Also known as Meperidine. Toxic metabolite normeperidine can accumulate causing seizures. Not recommended for chronic pain. Short-term use only.",
    "is_active": true
  },
  {
    "generic_name": "Oxycodone",
    "brand_names": ["OxyContin", "Roxicodone", "Oxynorm"],
    "active_ingredients": "Oxycodone HCl 10mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-9018",
    "nafdac_schedule": "schedule_2",
    "nafdac_schedule_date": "2005-01-01",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class A",
    "who_essential_medicine": false,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 7,
    "requires_photo_id": true,
    "therapeutic_class": "Opioid Analgesic",
    "pharmacological_class": "Semisynthetic Opioid",
    "mechanism_of_action": "Mu-opioid receptor agonist",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Pain management, Respiratory rate, Addiction signs, Constipation",
    "monitoring_frequency_days": 7,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "B",
    "breastfeeding_safe": false,
    "major_contraindications": ["Respiratory depression", "Acute asthma", "Paralytic ileus", "Severe hepatic impairment"],
    "allergy_cross_reactions": ["Other opioids", "Codeine"],
    "black_box_warning": true,
    "black_box_warning_text": "High abuse potential, respiratory depression risk, fatal overdose risk, extended-release formulations can be lethal if crushed",
    "major_drug_interactions": ["CNS depressants (respiratory depression)", "CYP3A4 inhibitors (increased oxycodone levels)", "Benzodiazepines (respiratory depression)", "Alcohol (fatal)"],
    "food_interactions": "Avoid alcohol completely, grapefruit may increase levels",
    "search_keywords": ["oxycodone", "oxycontin", "opioid", "chronic pain", "cancer pain"],
    "generic_variations": ["Oxycodone Hydrochloride"],
    "common_misspellings": ["Oxycodon", "Oxicodone", "Oxycodine"],
    "safer_alternatives": ["Morphine", "Tramadol (weaker)", "Tapentadol"],
    "cheaper_alternatives": ["Morphine", "Codeine (weaker)"],
    "notes": "Potent opioid for moderate to severe pain. High abuse potential. OxyContin (extended-release) is particularly problematic if crushed/dissolved.",
    "is_active": true
  },
  {
    "generic_name": "Hydrocodone",
    "brand_names": ["Vicodin", "Norco", "Lortab"],
    "active_ingredients": "Hydrocodone Bitartrate 5mg",
    "nafdac_approved": true,
    "nafdac_registration_number": "A4-9019",
    "nafdac_schedule": "schedule_2",
    "nafdac_schedule_date": "2014-10-06",
    "us_dea_schedule": "Schedule II",
    "uk_controlled_drug_class": "Class A",
    "who_essential_medicine": false,
    "requires_special_prescription": true,
    "requires_physician_only": true,
    "pharmacist_can_prescribe": false,
    "maximum_days_supply": 7,
    "requires_photo_id": true,
    "therapeutic_class": "Opioid Analgesic",
    "pharmacological_class": "Semisynthetic Opioid",
    "mechanism_of_action": "Mu-opioid receptor agonist",
    "is_controlled": true,
    "is_high_risk": true,
    "requires_monitoring": true,
    "monitoring_type": "Pain level, Respiratory function, Liver function (when combined with paracetamol), Addiction signs",
    "monitoring_frequency_days": 7,
    "addiction_risk": true,
    "abuse_potential": "severe",
    "minimum_age": 18,
    "maximum_age": null,
    "pregnancy_category": "C",
    "breastfeeding_safe": false,
    "major_contraindications": ["Respiratory depression", "Acute asthma", "Paralytic ileus"],
    "allergy_cross_reactions": ["Other opioids", "Codeine"],
    "black_box_warning": true,
    "black_box_warning_text": "High abuse and addiction potential, respiratory depression risk, hepatotoxicity risk when combined with acetaminophen",
    "major_drug_interactions": ["CNS depressants (respiratory depression)", "CYP3A4 inhibitors (increased levels)", "Benzodiazepines (respiratory depression)", "Alcohol (fatal, liver damage)"],
    "food_interactions": "Avoid alcohol completely",
    "search_keywords": ["hydrocodone", "vicodin", "norco", "opioid", "moderate pain"],
    "generic_variations": ["Hydrocodone Bitartrate"],
    "common_misspellings": ["Hydrocodon", "Hydrocadone", "Vicodine"],
    "safer_alternatives": ["Tramadol (weaker)", "Codeine (weaker)", "Tapentadol"],
    "cheaper_alternatives": ["Codeine combinations", "Tramadol"],
    "notes": "Often combined with paracetamol (acetaminophen). Reclassified from Schedule III to II in US (2014) due to abuse. Monitor liver function with combination products.",
    "is_active": true
  }
]
